Literature DB >> 237270

Changes in cyclic nucleotide metabolism in aorta and heart of neurogenically hypertensive rats: possible trigger mechanism of hypertension.

M S Amer, N Doba, D J Reis.   

Abstract

Changes in cyclic nucleotide metabolism similar to those characteristic of the chronic forms of hypertension were observed in an acute neurogenic form of hypertension in rats produced by electrolytic lesions of the nucleus tractus solitarii. These changes that were evident 2 hr after the lesions were made included decreased cyclic AMP levels in the heart, increased cGMP:cAMP ratio, cAMP phosphodiesterase (3':5'-cAMP 5'-nucleotidohydrolase, EC 3.1.4.17) and guanylyl cyclase (GTP pyrophosphate-lyase (cyclizing), EC 4.6.1.2) activities in the aorta and decreased snesitivity of adenylyl cyclase (ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1) in both the aorta and heart to stimulation by the beta-adrenergic stimulant isoproterenol. These changes appear to depend on catecholamine release and are not due to mechanical distortion secondary to the increased arterial pressure. These studies provide biochemical support to the concept that the sympathetic nervous system may play a critical role in the initiation of the hypertensive syndrome and that chronic hypertension could result from the fixation of the biochemical effects of increased sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 237270      PMCID: PMC432711          DOI: 10.1073/pnas.72.6.2135

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Cyclic guanosine 3',5'-monophosphate and gallbladder contraction.

Authors:  M S Amer
Journal:  Gastroenterology       Date:  1974-08       Impact factor: 22.682

2.  Effects of 6-hydroxydopamine on the perfused rat mesentery preparation.

Authors:  L Finch; G D Leach
Journal:  J Pharm Pharmacol       Date:  1970-07       Impact factor: 3.765

3.  A comparison of the effects of 6-hydroxydopamine immunosympathectomy and reserpine on the cardiovascular reactivity in the rat.

Authors:  L Finch; G D Leach
Journal:  J Pharm Pharmacol       Date:  1970-05       Impact factor: 3.765

4.  Sympathetic activity in essential hypertension.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1973-03-22       Impact factor: 91.245

Review 5.  Cyclic GMP.

Authors:  N D Goldberg; R F O'Dea; M K Haddox
Journal:  Adv Cyclic Nucleotide Res       Date:  1973

6.  Cyclic adenosine monophosphate and hypertension in rats.

Authors:  M S Amer
Journal:  Science       Date:  1973-02-23       Impact factor: 47.728

7.  Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man.

Authors:  J H Ball; N I Kaminsky; J G Hardman; A E Broadus; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

8.  A new enzymatic assay for guanosine 3':5'-cyclic monophosphate and its application to the ductus deferens of the rat.

Authors:  G Schultz; J G Hardman; K Schultz; J W Davis; E W Sutherland
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

9.  Aberrations of cyclic nucleotide metabolism in the hearts and vessels of hypertensive rats.

Authors:  M S Amer; A W Gomoll; J L Perhach; H C Ferguson; G R McKinney
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

10.  Supersensitivity and subsensitivity of the beta-adrenergic receptor in pineal gland regulated by catecholamine transmitter.

Authors:  T Deguchi; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

View more
  3 in total

1.  Decreased cAMP content of the hypothalamus of genetically hypertensive rats.

Authors:  G Schmid; K Hempel; A Heidland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

2.  Secretin and VIP-stimulated adenylate cyclase from rat heart. II. Impairment in spontaneous hypertension.

Authors:  P Chatelain; P Robberecht; P De Neef; J C Camus; D Heuse; J Christophe
Journal:  Pflugers Arch       Date:  1980-12       Impact factor: 3.657

3.  Reduced cAMP levels and glycogen phosphorylase activation in isoproterenol perfused SHR myocardium.

Authors:  R V Sharma; R C Gupta; M Ramanadham; R C Venema; R C Bhalla
Journal:  Basic Res Cardiol       Date:  1983 Nov-Dec       Impact factor: 17.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.